Natural compound tested to fight rare brain disease
NCT ID NCT04658823
Summary
This study tested whether a natural vitamin E compound called palm tocotrienols (HOV-12020) could slow down the progression of CADASIL, a rare inherited brain disease that causes strokes and cognitive decline. Fifty patients with confirmed CADASIL took either the study drug or a placebo for two years while researchers tracked whether they experienced new strokes, increased disability, or cognitive decline. The goal was to see if this natural supplement could help control the disease and prevent worsening symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CADASIL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Lariboisière APHP
Paris, 75010, France
Conditions
Explore the condition pages connected to this study.